Madhu Gowda, M.D.
Pulmonary Disease Physician in Seymour, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,271 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Madhu Gowda, M.D. reported a CMS MIPS final score of 100/100 - above the 83.1 national average - and filed 9,790 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 10K
- Part D claims, 2023
- 72%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Madhu Gowda, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
100 Top 7% higher than 93% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Madhu Gowda, M.D. sits
This provider among pulmonary disease physician peers
Across the 2,676 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Madhu Gowda, M.D. writes more Part D claims than 99% of them and scores higher on MIPS quality than 93% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Madhu Gowda, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Madhu Gowda, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Madhu Gowda, M.D.?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Connecticut
How Pulmonary Disease Physician compares to other specialties among Connecticut providers
Pulmonary Disease Physician ranks #74 among Connecticut's specialties (0.2% of in-state providers)
Each bar is a specialty's share of the Connecticut provider total, by primary NUCC taxonomy. The highlighted bar is Pulmonary Disease Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Madhu Gowda, M.D.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Pulmonary Disease Physician) - 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Pulmonary Disease Physician US NPIs
100/100 MIPS final score - 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Pulmonary Disease Physician. Quality dim: 94.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Madhu Gowda, M.D. appears in the CMS NPPES registry as a Pulmonary Disease Physician provider holding M.D. credentials at 17 WESTERMAN AVE, Seymour, CT, 06483, with a listed phone of (203) 888-9340. NPI 1104856921 was issued on 07/04/2006.
Medicare Part D records for calendar year 2023 show 9,790 prescription claims written by this provider, covering 768 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 27% brand-name and 72% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 94.7), compared with the national average of 83.1.
Pulmonary Disease Physician is a mid-sized specialty nationwide, with 9,271 enrolled providers across 53 states and an average of 1,457 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1104856921 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 07/04/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Madhu Gowda, M.D.'s current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1104856921 is the unique 10-digit identifier CMS uses to link Gowda across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Madhu Gowda, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$7.4K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
27% brand-name claims vs 72% generic, on 9,790 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 20,694
- Total Day Supply
- 604,225
- Brand vs Generic
- 27% brand / 72% generic
- Brand Drug Cost
- $2.0M
- Generic Drug Cost
- $257K
- Antibiotic Claims
- 314
Patient Demographics
- Average Patient Age
- 75.1 years
- Avg HCC Risk Score
- 1.56
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 58, 65-74: 315, 75-84: 292, 85+: 103
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Madhu Gowda, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Atorvastatin Calcium
Atorvastatin Calcium
601 claims
- Amlodipine Besylate
Amlodipine Besylate
499 claims
- Losartan Potassium
Losartan Potassium
448 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
411 claims
- Levothyroxine Sodium
Levothyroxine Sodium
338 claims
- Metoprolol Succinate
Metoprolol Succinate
336 claims
- Metformin Hcl
Metformin Hcl
244 claims
- Rosuvastatin Calcium 231
Rosuvastatin Calcium
231 claims
| Drug | Claims |
|---|---|
| Atorvastatin Calcium | 601 |
| Amlodipine Besylate | 499 |
| Losartan Potassium | 448 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 411 |
| Levothyroxine Sodium | 338 |
| Metoprolol Succinate | 336 |
| Metformin Hcl | 244 |
| Rosuvastatin Calcium | 231 |
| Symbicort Budesonide/Formoterol Fumarate | 222 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 222 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Madhu Gowda, M.D. fits within the Pulmonary Disease Physician landscape nationally.
Madhu Gowda, M.D.'s 9,790 claims are above the specialty average of 1,457.
Nearby Pulmonary Disease Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Gowda.
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Pulmonary Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is Madhu Gowda, M.D.'s specialty? ▼
How much does Madhu Gowda, M.D. prescribe under Medicare Part D? ▼
What is Madhu Gowda, M.D.'s Medicare quality score? ▼
Where is Madhu Gowda, M.D. located? ▼
What is Madhu Gowda, M.D.'s NPI number? ▼
Does Madhu Gowda, M.D. prescribe more brand-name or generic drugs? ▼
How many Pulmonary Disease Physician providers are there in the US? ▼
What drugs does Madhu Gowda, M.D. prescribe most often? ▼
Does Madhu Gowda, M.D. accept Medicare? ▼
How can I verify Madhu Gowda, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology